These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 20813165)
21. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation. Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932 [TBL] [Abstract][Full Text] [Related]
22. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Lin HC; Hsieh HM; Chen YH; Hu ML Neurotoxicology; 2009 Jul; 30(4):622-7. PubMed ID: 19635394 [TBL] [Abstract][Full Text] [Related]
23. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840 [TBL] [Abstract][Full Text] [Related]
24. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Rodrigo J; Fernández-Vizarra P; Castro-Blanco S; Bentura ML; Nieto M; Gómez-Isla T; Martínez-Murillo R; MartInez A; Serrano J; Fernández AP Neuroscience; 2004; 128(1):73-89. PubMed ID: 15450355 [TBL] [Abstract][Full Text] [Related]
25. Metallothionein-I and -III expression in animal models of Alzheimer disease. Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170 [TBL] [Abstract][Full Text] [Related]
26. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi. Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412 [TBL] [Abstract][Full Text] [Related]
27. Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations. Willis M; Hutter-Paier B; Wietzorrek G; Windisch M; Humpel C; Knaus HG; Marksteiner J Brain Res; 2007 Apr; 1143():199-207. PubMed ID: 17328871 [TBL] [Abstract][Full Text] [Related]
29. Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse. Zheng W; Wang T; Yu D; Feng WY; Nie YX; Stoltenberg M; Danscher G; Wang ZY J Alzheimers Dis; 2010; 20(1):323-31. PubMed ID: 20164588 [TBL] [Abstract][Full Text] [Related]
30. Effects of amyloid-β plaque proximity on the axon initial segment of pyramidal cells. León-Espinosa G; DeFelipe J; Muñoz A J Alzheimers Dis; 2012; 29(4):841-52. PubMed ID: 22337828 [TBL] [Abstract][Full Text] [Related]
31. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
32. β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors. Shrivastava AN; Kowalewski JM; Renner M; Bousset L; Koulakoff A; Melki R; Giaume C; Triller A Glia; 2013 Oct; 61(10):1673-86. PubMed ID: 23922225 [TBL] [Abstract][Full Text] [Related]
33. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
35. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques. Steinhoff T; Moritz E; Wollmer MA; Mohajeri MH; Kins S; Nitsch RM Neurobiol Dis; 2001 Aug; 8(4):647-54. PubMed ID: 11493029 [TBL] [Abstract][Full Text] [Related]
36. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor. Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193 [TBL] [Abstract][Full Text] [Related]
37. Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice. Doehner J; Madhusudan A; Konietzko U; Fritschy JM; Knuesel I J Alzheimers Dis; 2010; 19(4):1339-57. PubMed ID: 20061602 [TBL] [Abstract][Full Text] [Related]
38. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons. Gärtner U; Brückner MK; Krug S; Schmetsdorf S; Staufenbiel M; Arendt T Acta Neuropathol; 2003 Dec; 106(6):535-44. PubMed ID: 12923647 [TBL] [Abstract][Full Text] [Related]
39. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581 [TBL] [Abstract][Full Text] [Related]
40. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]